Cargando…
Quo vadis, biological treatment for psoriasis and psoriatic arthritis?
Psoriasis is a chronic autoimmune disease that affects approximately 2–3% of the world’s population. Although the cutaneous manifestations of the disease are the most prevalent, psoriasis is also associated with a systemic inflammation and various co-morbidities linked with autoinflammatory processe...
Autores principales: | Olszewska, Barbara, Adamski, Zygmunt, Czarnecka-Operacz, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041715/ https://www.ncbi.nlm.nih.gov/pubmed/30008638 http://dx.doi.org/10.5114/ada.2018.76086 |
Ejemplares similares
-
Contemporary treatment patterns in plaque psoriasis and psoriatic arthritis
por: Jenerowicz, Dorota, et al.
Publicado: (2020) -
Rheumatologie – quo vadis? Gesundheitssystem – quo vadis?
por: Puchner, Rudolf
Publicado: (2023) -
Application of Liposomes in Treatment of Rheumatoid Arthritis: Quo Vadis
por: Kapoor, Bhupinder, et al.
Publicado: (2014) -
Remdesivir: Quo vadis?()
por: De Clercq, Erik
Publicado: (2021) -
Structure and function of the epidermal barrier in patients with atopic dermatitis – treatment options. Part one
por: Pelc, Jagoda, et al.
Publicado: (2018)